These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8521917)

  • 1. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
    Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
    Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a Ca2+ channel agonist, Bay k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists.
    Czuczwar SJ; Gasior M; Turski WA; Kleinrok Z
    Eur J Pharmacol; 1994 Oct; 264(1):103-6. PubMed ID: 7530200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.
    Chapman AG; Smith SE; Meldrum BS
    Epilepsy Res; 1991 Jul; 9(2):92-6. PubMed ID: 1794356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
    Parsons CG; Gruner R; Rozental J
    Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
    Yamaguchi S; Donevan SD; Rogawski MA
    Epilepsy Res; 1993 Jul; 15(3):179-84. PubMed ID: 7693450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.
    Chapman AG; al-Zubaidy Z; Meldrum BS
    Eur J Pharmacol; 1993 Feb; 231(2):301-3. PubMed ID: 8453982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
    Donevan SD; Yamaguchi S; Rogawski MA
    J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Adrenoceptor blockade enhances the anticonvulsant effect of glutamate receptor antagonists against maximal electroshock.
    Luchowska E; Luchowski P; Wielosz M; Kleinrok Z; Urbanska EM
    Eur J Pharmacol; 2001 Nov; 431(2):209-14. PubMed ID: 11728427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice.
    Tutka P; Turski WA; Kleinrok Z; Czuczwar SJ
    J Neural Transm (Vienna); 1996; 103(3):307-14. PubMed ID: 8739842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPA/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid.
    Urbanska EM; Blaszczak P; Saran T; Kleinrok Z; Turski WA
    Eur J Pharmacol; 1999 Apr; 370(3):251-6. PubMed ID: 10334499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466.
    Stephens DN; Brown G
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1914-20. PubMed ID: 10630610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant and adverse effects of MK-801, LY 235959, and GYKI 52466 in combination with Ca2+ channel inhibitors in mice.
    Gasior M; Borowicz K; Kleinrok Z; Starownik R; Czuczwar SJ
    Pharmacol Biochem Behav; 1997 Apr; 56(4):629-35. PubMed ID: 9130287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
    Neuropharmacology; 1993 Sep; 32(9):895-900. PubMed ID: 7694171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
    Ruiz A; Durand J
    Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazepam dependence prevented by glutamate antagonists.
    Steppuhn KG; Turski L
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6889-93. PubMed ID: 8341715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
    Löscher W; Rundfeldt C; Hönack D
    Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excitatory amino acid antagonists and the anticonvulsive activity of conventional antiepileptic drugs.
    Kleinrok Z; Turski WA; Czuczwar SJ
    Pol J Pharmacol; 1995; 47(3):247-52. PubMed ID: 8714757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.
    Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
    Neuropharmacology; 1994 May; 33(5):619-24. PubMed ID: 7936096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.